Gerald Desler

Gerald Desler

Finanzdirektor/CFO bei VALIRX PLC

Vermögen: 4 833 $ am 31.05.2024

79 Jahre
Health Technology
Consumer Services
Finance

Ursprung des Netzwerks ersten Grades von Gerald Desler

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 21

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Gerald Desler

UnternehmenSektorVerknüpfte PersonenHauptposition
EQUUS TOTAL RETURN, INC. Investment Managers

Anthony Roger Moore

President

SpinX, Inc.

Seppo Olavi Mäkinen

Director/Board Member

BITTIUM OYJ Information Technology Services

Seppo Olavi Mäkinen

Director/Board Member

BIOPORTO A/S Medical Specialties

Seppo Olavi Mäkinen

Director/Board Member

Miscellaneous Commercial Services

Seppo Olavi Mäkinen

Chairman

University of Cambridge College/University

Kevin John Alexander

Adrian de Courcey

Graduate Degree

Masters Business Admin

Medical Specialties

Seppo Olavi Mäkinen

Director/Board Member

Electronic Equipment/Instruments

Seppo Olavi Mäkinen

Director/Board Member

Wallac Oy

Seppo Olavi Mäkinen

Director/Board Member

Miscellaneous Commercial Services

Seppo Olavi Mäkinen

Director/Board Member

Environmental Services

Seppo Olavi Mäkinen

Director/Board Member

Pharmaceuticals: Major

Seppo Olavi Mäkinen

Director/Board Member

Pharmaceuticals: Major

Seppo Olavi Mäkinen

Director/Board Member

University of Jyväskylä College/University

Seppo Olavi Mäkinen

Graduate Degree

King's College London College/University

Jacob Micallef

Doctorate Degree

Pharmaceuticals: Generic

Oliver de Giorgio-Miller

Chief Executive Officer

Medical/Nursing Services

Seppo Olavi Mäkinen

Director/Board Member

Miscellaneous Commercial Services

Seppo Olavi Mäkinen

Corporate Officer/Principal

Medical Specialties

Jacob Micallef

Chief Executive Officer

Medical Specialties

Jacob Micallef

Founder

Gene Expression Technologies Ltd.

Jacob Micallef

Founder

Valipharma Ltd.

Jacob Micallef

Founder

Sitrans Oy Ltd.

Seppo Olavi Mäkinen

Corporate Officer/Principal

Sarum Investment (SICAV) Plc

Oliver de Giorgio-Miller

Director/Board Member

VOLITIONRX LIMITED Medical Specialties

Kevin John Alexander

Satu Vainikka

Jacob Micallef

George S. Morris

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Investment Managers

Martin Gouldstone

Corporate Officer/Principal

Mediracer Oy

Seppo Olavi Mäkinen

Chairman

Medical Specialties

Seppo Olavi Mäkinen

Chairman

Biotechnology

Seppo Olavi Mäkinen

Director/Board Member

Imperial College Business School College/University

Jacob Micallef

Masters Business Admin

Medical Specialties

Seppo Olavi Mäkinen

Director/Board Member

WH Ireland Ltd. (Broker) Investment Banks/Brokers

Oliver de Giorgio-Miller

Analyst-Equity

Medical Specialties

Seppo Olavi Mäkinen

Director/Board Member

Neurotar Oy

Seppo Olavi Mäkinen

Director/Board Member

Taikon Advisor Oy

Seppo Olavi Mäkinen

Chairman

Miscellaneous Commercial Services

Martin Gouldstone

Director/Board Member

Packaged Software

Martin Gouldstone

Corporate Officer/Principal

St Thomas Hospital Medical School College/University

Jacob Micallef

Graduate Degree

Miscellaneous Commercial Services

Martin Gouldstone

Corporate Officer/Principal

HVIVO PLC Miscellaneous Commercial Services

Martin Gouldstone

Director/Board Member

BENEVOLENTAI Biotechnology

Martin Gouldstone

Corporate Officer/Principal

Biotechnology

Seppo Olavi Mäkinen

Director/Board Member

Statistik

International

Finnland 19
Vereinigtes Königreich 17
Dänemark 6
Vereinigte Staaten 4
Deutschland 4

Sektoral

Health Technology 17
Commercial Services 9
Finance 6
Consumer Services 6
Technology Services 3

Operativ

Director/Board Member 104
Corporate Officer/Principal 33
Chairman 23
Independent Dir/Board Member 12
Chief Executive Officer 11
  1. Börse
  2. Insiders
  3. Gerald Desler
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT